Global Pediatric Health (Apr 2015)

Asthma Controller Medications for Children in Japan

  • Shota Hamada DrPH,
  • Hironobu Tokumasu MD, MPH,
  • Akira Sato MD, MPH,
  • Masahiro Iwasaku MD,
  • Koji Kawakami MD, PhD

DOI
https://doi.org/10.1177/2333794X15577790
Journal volume & issue
Vol. 2

Abstract

Read online

Background. Treatment and management strategies for asthma in children are generally consistent internationally, but prescription of antiasthma drugs differs among countries. The objective of this study was to examine the prescribing patterns of antiasthma drugs, particularly controller medications, in children. Methods. A retrospective cohort study was performed in children with asthma using an administrative claims database in Japan. Results . A total of 1149 preschool-age and 3226 school-age children were identified. Leukotriene receptor antagonists were prescribed for about 80% of the children. Long-acting β-agonists were prescribed for 87.6% and 59.6% of preschool-age and school-age children, respectively, whereas prescriptions of inhaled corticosteroids had lower rates of 8.2% and 16.5%, respectively. In an examination of prescriptions at 1-month intervals, a relatively high number of children were prescribed bronchodilators without anti-inflammatory agents. Conclusion . Our findings suggest that asthma care for children in Japan can be improved through changes in drug prescriptions.